The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Are current family-history based colorectal cancer screening guidelines adequate for early detection and potential prevention of young-onset cases?
 
Y. Nancy You
No Relationships to Disclose
 
Miguel A. Rodriguez-Bigas
No Relationships to Disclose
 
George J. Chang
Consulting or Advisory Role - 11 Health; Johnson & Johnson; Medicaroid; MORE Health
Research Funding - Agendia
 
Brian K. Bednarski
No Relationships to Disclose
 
John Michael Skibber
No Relationships to Disclose
 
Maureen E Mork
No Relationships to Disclose
 
Julie B Moskowitz
No Relationships to Disclose
 
Sa Thi Nguyen
No Relationships to Disclose
 
Selvi Thirumurthi
No Relationships to Disclose
 
Patrick M. Lynch
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - Lutris; MolecularMatch; Navire
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer Health; Boehringer Ingelheim; Boston Biomedical; Daiichi Sankyo; EMD Serono; EMD Serono; Genentech; GlaxoSmithKline; HalioDx; Holy Stone Healthcare; Inivata; Ipsen; Jacobio; Jazz Pharmaceuticals; Lilly; Lutris; Merck; Natera; Navire; Novartis; Pfizer; Pierre Fabre; Redx Pharma; Repare Therapeutics; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Eduardo Vilar Sanchez
Consulting or Advisory Role - Janssen Research & Development; Recursion Pharmaceuticals
Travel, Accommodations, Expenses - Janssen Research & Development